Are all outcomes in chronic heart failure rated equally? An argument for a patient-centred approach to outcome assessment.

Abstract:

:Chronic heart failure (CHF) is a multi-dimensional and complex syndrome. Outcome measures are important for determining both the efficacy and quality of care and capturing the patient's perspective in evaluating the outcomes of health care delivery. Capturing the patient's perspective via patient-reported outcomes is increasingly important; however, including objective measures such as mortality would provide more complete account of outcomes important to patients. Currently, no single measure for CHF outcomes captures all dimensions of the quality of care from the patient's perspective. To describe the role of outcome measures in CHF from the perspective of patients, a structured literature review was undertaken. This review discusses the concepts and methodological issues related to measurement of CHF outcomes. Outcome assessment at the level of the patient, provider and health care system were identified as being important. The perspectives of all stakeholders should be considered when developing an outcomes measurement suite to inform CHF health care. This paper recommends that choice of outcome measures should depend on their ability to provide a comprehensive, comparable, meaningful and accurate assessment that are important to patient.

journal_name

Heart Fail Rev

journal_title

Heart failure reviews

authors

Chang S,Newton PJ,Inglis S,Luckett T,Krum H,Macdonald P,Davidson PM

doi

10.1007/s10741-012-9369-0

subject

Has Abstract

pub_date

2014-03-01 00:00:00

pages

153-62

issue

2

eissn

1382-4147

issn

1573-7322

journal_volume

19

pub_type

杂志文章,评审
  • Expanded algorithm for managing patients with acute decompensated heart failure.

    abstract::Heart failure is a complex disease process, the manifestation of various cardiac and noncardiac abnormalities. General treatment approaches for heart failure have remained the same over the past decades despite the advent of novel therapies and monitoring modalities. In the same vein, the readmission rates for heart f...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9697-9

    authors: Njoroge JN,Cheema B,Ambrosy AP,Greene SJ,Collins SP,Vaduganathan M,Mebazaa A,Chioncel O,Butler J,Gheorghiade M

    更新日期:2018-07-01 00:00:00

  • The management of conditioned nutritional requirements in heart failure.

    abstract::Patients suffering from congestive heart failure exhibit impaired myocardial energy production, myocyte calcium overload and increased oxidative stress. Nutritional factors known to be important for myocardial energy production, calcium homeostasis and the reduction of oxidative stress, such as thiamine, riboflavin, p...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-006-9195-3

    authors: Allard ML,Jeejeebhoy KN,Sole MJ

    更新日期:2006-03-01 00:00:00

  • Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges.

    abstract::Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, life-threatening disease characterized by deposition of insoluble amyloid fibrils in the myocardium, resulting in cardiac structural and functional abnormalities and ultimately heart failure. Disease frequency is reportedly lower in women than men, but s...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-10010-8

    authors: Bruno M,Castaño A,Burton A,Grodin JL

    更新日期:2021-01-01 00:00:00

  • Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?

    abstract::Acute heart failure syndromes (AHFS) are associated with the rapid onset of heart failure (HF) signs and symptoms. Hospitalizations for AHFS continue to rise and are associated with significant mortality and morbidity. Several pharmacological agents are currently approved for the treatment of AHFS, but their use is as...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-009-9136-z

    authors: Khan H,Metra M,Blair JE,Vogel M,Harinstein ME,Filippatos GS,Sabbah HN,Porchet H,Valentini G,Gheorghiade M

    更新日期:2009-12-01 00:00:00

  • Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review.

    abstract::Heart failure with preserved ejection fraction (HFpEF) is a common disorder generating high mortality and important morbidity prevalence, with a very limited medical treatment available. Studies have shown that the pathophysiological hallmark of this condition is an elevated left intra-atrial pressure (LAP), exertiona...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09787-0

    authors: Burlacu A,Simion P,Nistor I,Covic A,Tinica G

    更新日期:2019-09-01 00:00:00

  • Structural and functional abnormalities in iron-depleted heart.

    abstract::Iron deficiency (ID) is a common and ominous comorbidity in heart failure (HF) and predicts worse outcomes, independently of the presence of anaemia. Accumulated data from animal models of systemic ID suggest that ID is associated with several functional and structural abnormalities of the heart. However, the exact ro...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9738-4

    authors: Kobak KA,Radwańska M,Dzięgała M,Kasztura M,Josiak K,Banasiak W,Ponikowski P,Jankowska EA

    更新日期:2019-03-01 00:00:00

  • Heart failure with preserved ejection fraction: a nephrologist-directed primer.

    abstract::There is substantial causal and consequential interaction between the ever-growing heart failure and renal failure patients. Half of the patients with heart failure (HF) have preserved left ventricular ejection fraction (HFpEF), which is difficult to diagnose and rising in prevalence relative to HF with reduced EF (HF...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9619-2

    authors: Afsar B,Rossignol P,van Heerebeek L,Paulus WJ,Damman K,Heymans S,van Empel V,Sag A,Maisel A,Kanbay M

    更新日期:2017-11-01 00:00:00

  • Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

    abstract::Cardiac hypertrophy is promoted by adrenergic over-activation and represents an independent risk factor for cardiovascular morbidity and mortality. The basic knowledge about mechanisms by which sustained adrenergic activation promotes myocardial growth, as well as understanding how structural changes in hypertrophied ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-007-9007-4

    authors: Osadchii OE

    更新日期:2007-03-01 00:00:00

  • Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.

    abstract::Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide, with co-morbidities contributing to the overall severity and mortality of the disease. The incidence and prevalence of cardiovascular disease among COPD patients are high. Both disorders often co-exist, mainly due to smoking, but they al...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9646-z

    authors: Petta V,Perlikos F,Loukides S,Bakakos P,Chalkias A,Iacovidou N,Xanthos T,Tsekoura D,Hillas G

    更新日期:2017-11-01 00:00:00

  • Cardiotoxicity in HER2-positive breast cancer patients.

    abstract::Due to the recent advances in diagnosis and management of patients with HER2-positive breast cancer, especially through novel HER2-targeted agents, cardiotoxicity becomes an emerging problem. Although chemotherapy significantly increases survival, the risk of cardiovascular disease development is high and still undere...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-10072-8

    authors: Gonciar D,Mocan L,Zlibut A,Mocan T,Agoston-Coldea L

    更新日期:2021-01-06 00:00:00

  • Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample.

    abstract::We aimed to study the cardiovascular and economic burden of diabetes mellitus (DM) in patients hospitalized for heart failure (HF) in the US and to assess the recent temporal trend. Data from the National Inpatient Sample were analyzed between 2005 and 2014. The prevalence of DM increased from 40.4 to 46.5% in patient...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-10012-6

    authors: Mekhaimar M,Dargham S,El-Shazly M,Al Suwaidi J,Jneid H,Abi Khalil C

    更新日期:2020-09-15 00:00:00

  • Classical inotropes and new cardiac enhancers.

    abstract::Acute heat failure syndromes are a heterogenous group of conditions. Chronic heart failure exacerbations represent the vast majority of cases. Pathophysiologic mechanisms, such as hypotension with peripheral tissue hypoperfusion, renal function impairment and myocardial ischemia and injury, adversely affect patients' ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-007-9014-5

    authors: Parissis JT,Farmakis D,Nieminen M

    更新日期:2007-06-01 00:00:00

  • Interactions between cytokines and neurohormonal systems in the failing heart.

    abstract::The prognosis for patients with congestive heart failure (CHF) has been improved as a result of the use of angiotensin converting enzyme inhibitors and beta-adrenergic receptor blockers. The success of these therapies underscores the pathogenic role of neurohormonal activation in CHF. Clinical and experimental evidenc...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/a:1011405926588

    authors: Kan H,Finkel MS

    更新日期:2001-03-01 00:00:00

  • Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.

    abstract:BACKGROUND:Whether mechanical restraint of the left ventricle (LV) can influence remodeling following myocardial infarction (MI) remains poorly understood. The following discussion details three studies examining the effects of surgically placing a cardiac support device (CSD) over the entire epicardial surface, on inf...

    journal_title:Heart failure reviews

    pub_type: 杂志文章

    doi:10.1007/s10741-005-4640-2

    authors: Blom AS,Pilla JJ,Gorman RC 3rd,Gorman JH,Mukherjee R,Spinale FG,Acker MA

    更新日期:2005-06-01 00:00:00

  • Beta-adrenergic stimulation and myocardial function in the failing heart.

    abstract::The sympathetic nervous system provides the most powerful stimulation of cardiac function, brought about via norepinephrine and epinephrine and their postsynaptic beta-adrenergic receptors. More than 30 years after the first use of practolol in patients with heart failure beta blockers are now the mainstay of the phar...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-008-9132-8

    authors: El-Armouche A,Eschenhagen T

    更新日期:2009-12-01 00:00:00

  • Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

    abstract::The pathophysiology of heart failure (HF) is characterized by an abnormal activation of neurohumoral systems, including the sympathetic nervous and the renin-angiotensin-aldosterone systems, which have long-term deleterious effects on the disease progression. Perpetuation of this neurohumoral activation is partially d...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-014-9427-x

    authors: Sousa-Pinto B,Ferreira-Pinto MJ,Santos M,Leite-Moreira AF

    更新日期:2014-11-01 00:00:00

  • Patient selection for mechanical circulatory support.

    abstract::Heart failure continues to be associated with high morbidity and mortality. Over the past decade, left ventricular assist devices have been shown to improve the survival and quality of life. However, it is quite clear that very sick patients do not do as well, and it is therefore imperative to select patients at the p...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9316-0

    authors: Gilotra NA,Russell SD

    更新日期:2013-01-01 00:00:00

  • Ventricular restoration--a surgical approach to reverse ventricular remodeling.

    abstract::Congestive heart failure is most often caused by scar from coronary occlusion. The transition from occluded vessel to scar to dilation results in a remodeled ventricle that changes shape from ellipse to sphere. This shape change following an index event is called remodeling and a surgical approach for restoration (bri...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-005-6801-8

    authors: Buckberg GD

    更新日期:2004-10-01 00:00:00

  • How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

    abstract::Many factors contribute to the pathophysiology and progression of heart failure (HF), offering the potential for many synergistic therapeutic approaches to its management. For patients, who have systolic HF, prolonged QRS and receiving guideline-indicated pharmacological therapy, cardiac resynchronization therapy (CRT...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9351-x

    authors: Buga L

    更新日期:2012-11-01 00:00:00

  • Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.

    abstract::There are multiple intrinsic mechanisms for diastolic dysfunction ranging from molecular to structural derangements in ventricular myocardium. The molecular mechanisms regulating the progression from normal diastolic function to severe dysfunction still remain poorly understood. Recent studies suggest a potentially im...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-016-9569-0

    authors: Mikhailov AT,Torrado M

    更新日期:2016-11-01 00:00:00

  • Anti-fibrotic effects of curcumin and some of its analogues in the heart.

    abstract::Cardiac fibrosis stems from the changes in the expression of fibrotic genes in cardiac fibroblasts (CFs) in response to the tissue damage induced by various cardiovascular diseases (CVDs) leading to their transformation into active myofibroblasts, which produce high amounts of extracellular matrix (ECM) proteins leadi...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09854-6

    authors: Gorabi AM,Hajighasemi S,Kiaie N,Rosano GMC,Sathyapalan T,Al-Rasadi K,Sahebkar A

    更新日期:2020-09-01 00:00:00

  • Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes.

    abstract::Genomic mechanisms of mineralocorticoid action have been increasingly elucidated over the past four decades. In renal epithelia, the main effect is an increase in sodium transport through activation and de novo synthesis of epithelial sodium channels. This leads to increased concentrations of intracellular sodium acti...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-005-2347-z

    authors: Wehling M

    更新日期:2005-01-01 00:00:00

  • Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training.

    abstract::Despite remarkable progress in the therapeutic approach of patients with chronic heart failure (CHF), exercise intolerance remains one of the hallmarks of the disease. During the past two decades, evidence has accumulated to underscore the key role of both endothelial dysfunction and skeletal muscle wasting in the pro...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9324-0

    authors: Conraads VM,Van Craenenbroeck EM,De Maeyer C,Van Berendoncks AM,Beckers PJ,Vrints CJ

    更新日期:2013-01-01 00:00:00

  • Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly.

    abstract::Healing after myocardial infarction (MI) is a well-orchestrated time-dependent process that involves inflammation, tissue repair with extracellular collagen matrix (ECCM) deposition and scar formation, and remodeling of myocardial structure, matrix, vasculature, and function. Rapid early ECCM degradation followed by s...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-008-9090-1

    authors: Jugdutt BI

    更新日期:2008-12-01 00:00:00

  • Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart.

    abstract::The development of a diabetic cardiomyopathy is a multifactorial process, and evidence is accumulating that defects in intracellular free calcium concentration [Ca2+]i or its homeostasis are related to impaired mechanical performance of the diabetic heart leading to a reduction in contractile dysfunction. Defects in r...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9663-y

    authors: Singh RM,Waqar T,Howarth FC,Adeghate E,Bidasee K,Singh J

    更新日期:2018-01-01 00:00:00

  • Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

    abstract::Cardiac resynchronization therapy (CRT) has revolutionized the treatment of selected patients with systolic heart failure. It is well recognized, however, that the symptomatic response to and the outcome of CRT is highly variable. The degree of pre-implant mechanical dyssynchrony and the extent as well as the localiza...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-010-9213-3

    authors: Leyva F,Foley PW

    更新日期:2011-05-01 00:00:00

  • Preconditioning in humans.

    abstract::Brief ischemia to the myocardium initiates a cascade of biochemical events in cardiac myocytes that protects the heart muscle during subsequent ischemic insults. This phenomenon is called ischemic preconditioning. If an acute myocardial infarction is preceded by preinfarction angina, it results in smaller infarction s...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-007-9037-y

    authors: Rezkalla SH,Kloner RA

    更新日期:2007-12-01 00:00:00

  • Symptom burden in heart failure: assessment, impact on outcomes, and management.

    abstract::Evidence-based management has improved long-term survival in patients with heart failure (HF). However, an unintended consequence of increased longevity is that patients with HF are exposed to a greater symptom burden over time. In addition to classic symptoms such as dyspnea and edema, patients with HF frequently suf...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-016-9581-4

    authors: Alpert CM,Smith MA,Hummel SL,Hummel EK

    更新日期:2017-01-01 00:00:00

  • Effect of antidepressants on death in patients with heart failure: a systematic review and meta-analysis.

    abstract::Depression is associated with an increased risk of death in patients with heart failure (HF); however, the association between the use of antidepressants and HF prognoses remains controversial. Therefore, this meta-analysis aimed to evaluate the effect of antidepressants on the risk of death in HF patients. We retriev...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09850-w

    authors: He W,Zhou Y,Ma J,Wei B,Fu Y

    更新日期:2020-11-01 00:00:00

  • Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.

    abstract::Uric acid, the metabolic mediator of gout and urate renal stones, is associated with increased cardiovascular risk burden. Hyperuricemia is an old emerging metabolic disorder, and interaction among uric acid and cardiovascular diseases has been clearly described. Several illness including hypertension, myocardial infa...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09869-z

    authors: Borghi C,Palazzuoli A,Landolfo M,Cosentino E

    更新日期:2020-01-01 00:00:00